ArticleLancet (London, England)2020
Encouraging results from phase 1/2 COVID-19 vaccine trials.
Naor Bar-Zeev et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ArticleLancet (London, England)2020
Naor Bar-Zeev et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.